The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: Cotranslational RNA encapsidation and limitation of Gag protein confer specificity

被引:77
|
作者
Griffin, SDC [1 ]
Allen, JF [1 ]
Lever, AML [1 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
关键词
D O I
10.1128/JVI.75.24.12058-12069.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Deletion of a region of the human immunodeficiency virus type 2 (HIV-2) 5' leader RNA reduces genomic RNA encapsidation to about 5% that of wild-type virus with no defect in viral protein production but severely limits virus spread in Jurkat T cells, indicating that this region contains a major cis-acting encapsidation signal, or psi (psi). Being upstream of the major splice donor, it is present on all viral transcripts. We have shown that HIV-2 selects its genomic RNA for encapsidation cotranslationally, rendering wild-type HIV-2 unable to encapsidate vector RNAs in trans. Virus with psi deleted, however, encapsidates an HIV-2 vector, demonstrating competition for Gag protein. HIV-2 overcomes the lack of packaging signal location specificity by two novel mechanisms, cotranslational packaging and competition for limiting Gag polyprotein.
引用
收藏
页码:12058 / 12069
页数:12
相关论文
共 50 条
  • [1] Binding properties of human immunodeficiency virus type-2 (HIV-2) RNA corresponding to the packaging signal to its nucleocapsid protein
    Tsukahara, T
    Komatsu, H
    Kubo, M
    Obata, F
    Tozawa, H
    BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL, 1996, 40 (01): : 33 - 42
  • [2] Requirements for RNA heterodimerization of the human immunodeficiency virus type 1 (HIV-1) and HIV-2 genomes
    Dirac, AMG
    Huthoff, H
    Kjems, J
    Berkhout, B
    JOURNAL OF GENERAL VIROLOGY, 2002, 83 : 2533 - 2542
  • [3] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 (HIV-2)
    HUGHES, A
    CORRAH, T
    BLOOD REVIEWS, 1990, 4 (03) : 158 - 164
  • [4] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 (HIV-2) - PACKAGING SIGNAL AND ASSOCIATED NEGATIVE REGULATORY ELEMENT
    GARZINODEMO, A
    GALLO, RC
    ARYA, SK
    HUMAN GENE THERAPY, 1995, 6 (02) : 177 - 184
  • [5] Circulation of Human Immunodeficiency Virus Type-2 (HIV-2) in Mozambique
    Sema, C. A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E163 - E163
  • [6] TYPE-2 HUMAN IMMUNODEFICIENCY VIRUS (HIV-2) INFECTION IN THE USSR
    POKROVSKY, VV
    SUVOROVA, ZK
    MANGUSHEV, TN
    ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1988, (10): : 18 - &
  • [7] HEAT INACTIVATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 (HIV-2)
    GREGERSEN, JP
    HILFENHAUS, J
    LEMP, JF
    JOURNAL OF BIOLOGICAL STANDARDIZATION, 1989, 17 (04): : 377 - 379
  • [8] Human Immunodeficiency Virus Type 2 (HIV-2) EU-Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update
    Charpentier, Charlotte
    Berzow, Dirk
    Le Hingrat, Quentin
    Kaiser, Rolf
    Gomes, Perpetua
    Miranda, Ana Claudia
    Damond, Florence
    Ghosn, Jade
    van Kampen, Jeroen J. A.
    Jensen, Bjoern-Erik Ole
    Boehm, Michael
    Wensing, Annemarie M. J.
    Descamps, Diane
    Obermeier, Martin
    CLINICAL INFECTIOUS DISEASES, 2025,
  • [9] Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors
    Poeschla, E
    Gilbert, J
    Li, XQ
    Huang, SA
    Ho, A
    Wong-Staal, F
    JOURNAL OF VIROLOGY, 1998, 72 (08) : 6527 - 6536
  • [10] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-II (HIV-2)
    SORIANO, V
    TOR, J
    RIBERA, A
    MUGA, R
    REVISTA CLINICA ESPANOLA, 1990, 186 (08): : 394 - 399